Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Ginseng and Salviae herbs play a role as immune activators and modulate immune responses during influenza virus infection.

Quan FS, Compans RW, Cho YK, Kang SM.

Vaccine. 2007 Jan 4;25(2):272-82. Epub 2006 Aug 10.

PMID:
16945454
2.

Influenza ("Bird Flu"), inflammation and anti-inflammatory/analgesic drugs.

Rainsford KD.

Inflammopharmacology. 2006 Mar;14(1-2):2-9. Review.

PMID:
16835706
3.

A novel recombinant virus-like particle vaccine for prevention of porcine parvovirus-induced reproductive failure.

Antonis AF, Bruschke CJ, Rueda P, Maranga L, Casal JI, Vela C, Hilgers LA, Belt PB, Weerdmeester K, Carrondo MJ, Langeveld JP.

Vaccine. 2006 Jun 29;24(26):5481-90. Epub 2006 Apr 18.

PMID:
16730104
4.

Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains.

LoBue AD, Lindesmith L, Yount B, Harrington PR, Thompson JM, Johnston RE, Moe CL, Baric RS.

Vaccine. 2006 Jun 12;24(24):5220-34. Epub 2006 Apr 18.

PMID:
16650512
5.

Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice.

Pushko P, Tumpey TM, Bu F, Knell J, Robinson R, Smith G.

Vaccine. 2005 Dec 30;23(50):5751-9. Epub 2005 Aug 15.

PMID:
16143432
7.
8.

Assembly and budding of influenza virus.

Nayak DP, Hui EK, Barman S.

Virus Res. 2004 Dec;106(2):147-65. Review.

PMID:
15567494
9.

Impaired T- and B-cell development in Tcl1-deficient mice.

Kang SM, Narducci MG, Lazzeri C, Mongiovì AM, Caprini E, Bresin A, Martelli F, Rothstein J, Croce CM, Cooper MD, Russo G.

Blood. 2005 Feb 1;105(3):1288-94. Epub 2004 Oct 12.

10.

From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza.

Wood JM, Robertson JS.

Nat Rev Microbiol. 2004 Oct;2(10):842-7. Review.

PMID:
15378048
11.

Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus.

Asahi-Ozaki Y, Yoshikawa T, Iwakura Y, Suzuki Y, Tamura S, Kurata T, Sata T.

J Med Virol. 2004 Oct;74(2):328-35.

PMID:
15332283
13.

Confronting the avian influenza threat: vaccine development for a potential pandemic.

Stephenson I, Nicholson KG, Wood JM, Zambon MC, Katz JM.

Lancet Infect Dis. 2004 Aug;4(8):499-509. Review.

PMID:
15288823
14.

Immunization with hepatitis C virus-like particles induces humoral and cellular immune responses in nonhuman primates.

Jeong SH, Qiao M, Nascimbeni M, Hu Z, Rehermann B, Murthy K, Liang TJ.

J Virol. 2004 Jul;78(13):6995-7003.

15.

Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines.

Webby RJ, Perez DR, Coleman JS, Guan Y, Knight JH, Govorkova EA, McClain-Moss LR, Peiris JS, Rehg JE, Tuomanen EI, Webster RG.

Lancet. 2004 Apr 3;363(9415):1099-103.

PMID:
15064027
16.

Enhancement of mucosal immune responses by chimeric influenza HA/SHIV virus-like particles.

Guo L, Lu X, Kang SM, Chen C, Compans RW, Yao Q.

Virology. 2003 Sep 1;313(2):502-13.

18.

Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes.

Qiao CL, Yu KZ, Jiang YP, Jia YQ, Tian GB, Liu M, Deng GH, Wang XR, Meng QW, Tang XY.

Avian Pathol. 2003 Feb;32(1):25-32.

PMID:
12745375
20.

Cellular immunity and memory to respiratory virus infections.

Woodland DL, Hogan RJ, Zhong W.

Immunol Res. 2001;24(1):53-67. Review.

PMID:
11485209

Supplemental Content

Support Center